Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis - Wikidata - awgldk - TriplyDB

Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

http://www.wikidata.org/entity/Q36566861

about

Bacterial infections in cirrhosis: A critical review and practical guidance Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology Increased survival of cirrhotic patients with septic shock.Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis.Risk factors and outcome of bacterial infections in cirrhosis Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis New antibiotic strategies in patients with cirrhosis and bacterial infection.Defining acute-on-chronic liver failure: East, West or Middle ground?Sepsis in cirrhosis: emerging concepts in pathogenesis, diagnosis and management.Acute on Chronic Liver Failure-What is in a 'Definition'?Liver - guardian, modifier and target of sepsis.Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.Critical Care management of the cirrhotic patient awaiting liver transplant in the Intensive Care Unit.Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.The impact of infections on delisting patients from the liver transplantation waiting list.The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study.Mortality after urinary tract infections in patients with advanced cirrhosis - Relevance of acute kidney injury and comorbidities.The impact of obesity in cirrhotic patients with septic shock: a retrospective cohort study.Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Acute-on-chronic liver failure in cirrhosis.Response to the clinical course and short-term mortality of cirrhotic patients with non-spontaneous bacterial peritonitis infections.Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.Spontaneous bacterial peritonitis and other infections Intensive Care Therapy for Patients with Advanced Liver Diseases Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure

P2860

Q26766663-C62E400B-473C-443E-89C3-A02252AEF770 Q26865028-CB44F079-14AB-4042-9088-64065EB34D04 Q33754347-7282141E-F34A-4D4B-9579-F87934E0D82D Q35221810-BF0712A7-EF7F-4DFF-A799-DEFF90B1BC16 Q36085592-89F7B5F4-6420-4E0B-BAA8-438526F69A7C Q37206442-81DCB8F6-EB13-49C5-9CA8-3BE55B1F100E Q37629681-B528E918-086F-435C-8C0C-0E886FBD10CB Q38432555-7C0AE0C8-CFC1-41EA-90E2-BE6806C2CF80 Q38606723-B16C5054-9EF5-41D3-9CC5-682AD1B547A4 Q38630335-0678C83D-E3E9-4E6B-B3E0-157DD0CB5AB9 Q38898328-45DC0EAA-3C4A-4059-B20C-FB1BF6D359D5 Q38982106-0660B997-B1A9-415E-B764-28520CA14545 Q39031051-60CFD7AC-C9FF-47EA-8A4D-7BFE54C23572 Q39323851-DDDD2AD8-1136-4B3F-ACAF-0D53C678CFDC Q39422269-8CB1E23E-EF82-4F48-816A-65605ACFEDBD Q39455604-48FC0EEA-BEA0-4618-8BC8-F5B6E58C52D4 Q40253849-F08BE68D-13B5-4971-AFB9-54C2AC16E962 Q40629864-4EAFC21C-EC88-448E-AC13-651F32853DEF Q41471248-4E8F75F5-8802-4777-97EA-F606AD82E8AF Q42279846-F2F9A543-B091-4036-AA7E-BF14C0CB49EC Q44877545-CE465721-72EC-4C30-884B-37D7A6A67501 Q45394131-83F7B0F0-0A4A-4975-ADB2-B0303A2A5BA4 Q46095596-FB3DEAF4-B21F-4F81-BE4E-FCBDC466DB97 Q53840842-641E17E8-7F6F-477F-94F2-1A437D9903E6 Q55339985-96A47E7C-6B06-4684-80B2-C9A6E5DBDC9B Q56925157-C1F487D3-A13C-4FC9-9FB6-81A22640926A Q57824678-D0A3829D-AB90-48F2-BAA0-EE8AF6CB385A Q57824689-77448BC5-88F7-4100-B41E-44F0A7BA8553

P2860

Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

http://www.wikidata.org/entity/Q36566861

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@ast

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@en

type

label

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@ast

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@en

prefLabel

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@ast

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@en

P1433

Q36566861-E8133307-D2DB-47EF-BCD8-F5E09CE730C1

P1476

Q36566861-F68D2FFF-9A15-4AA4-ABF6-BA0109228F4E

P2093

Q36566861-2FA8D6CD-2DAE-44C0-97B9-F08066C188EC

Q36566861-39B09BCC-AD79-47FB-886F-0846E0021644

Q36566861-4F75957A-FE14-458C-B3A0-2C7873D6DEAC

Q36566861-69F0816A-6EE3-4058-927F-A64FD685AB93

Q36566861-7C6EEC20-CDFE-49C3-96F4-940EBCFAF8CA

Q36566861-8163D9D8-CCFF-41B2-A608-BD03933C00EB

Q36566861-9D27BA05-C0AC-4C16-9F5C-5EDC5F14566C

Q36566861-AF88055F-DE26-4830-A2BD-BB4152888FCF

Q36566861-C7CADEB2-E4F9-4989-BFBA-50C3DE7AEF67

Q36566861-CF12B472-414C-478F-9197-8790591F3268

P2860

Q36566861-249BFA3D-59A5-44F3-ABAD-E883B86717F0

Q36566861-384042DB-8AD9-43F5-9D1D-024FB14D2BCC

Q36566861-3F2AD8A2-B4BB-4659-8D45-6985FE783752

Q36566861-41DFAD71-5A51-4ACC-9452-BBBEFC9698C9

Q36566861-450C56CB-862D-46B3-AFB8-D192AC26D745

Q36566861-54C94FAF-6EB7-4927-9A2F-626BD656AA36

Q36566861-5506F9F7-0E2E-42B6-9612-7870BC95F2A1

Q36566861-6B14B584-14B4-45A3-9FB2-480C98FCF279

Q36566861-6B4775F1-FBDD-4AB0-96C0-86E77A50A74D

Q36566861-7147026D-1404-4D34-8004-81C14DAD113D

P304

Q36566861-6B53E226-874D-4789-BEB2-299732A67DB3

P31

Q36566861-CB1C9630-4396-4DB5-8CF2-EDFB0C0F1FBA

P356

Q36566861-415B9D7C-5017-4AC1-86CC-CA8ABEF6CCC0

P407

Q36566861-71A16896-80FB-4A9A-8EDB-FFCA7D9340BA

P433

Q36566861-F2C4C4B6-3E81-4FEB-8ED1-6FC60B19BB0D

P478

Q36566861-60E99515-5B83-4B44-A156-6968A3349DF3

P50

Q36566861-EDAA1255-13EB-42C8-B105-E4ACF5062767

P577

Q36566861-EA2C8F5A-0D52-40CA-87BB-C06E78BD3CBE

P5875

Q36566861-9B19EE92-68F3-4260-BE1D-074F3B2AAE03

P698

Q36566861-CEE5157E-0334-407F-921F-B07181F90C9D

P921

Q36566861-ED85442C-C4F6-448C-B446-B621360FCE6C

P932

Q36566861-55AE9052-1642-4058-82F4-A39C3989DDEA

P356

P1433

P1476

Antimicrobial therapeutic dete ...... among patients with cirrhosis

@en

P2093

Abdulmajeed Al Abdulkareem

http://www.w3.org/2001/XMLSchema#string

Anand Kumar

http://www.w3.org/2001/XMLSchema#string

Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group

http://www.w3.org/2001/XMLSchema#string

Daniel Feinstein

http://www.w3.org/2001/XMLSchema#string

Gordon Wood

http://www.w3.org/2001/XMLSchema#string

Hani M Tamim

http://www.w3.org/2001/XMLSchema#string

Joseph E Parrillo

http://www.w3.org/2001/XMLSchema#string

Nehad Al-Shirawi

http://www.w3.org/2001/XMLSchema#string

Peter Dodek

http://www.w3.org/2001/XMLSchema#string

Sandra Dial

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Early goal-directed therapy in the treatment of severe sepsis and septic shock

A model to predict survival in patients with end-stage liver disease

A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients

APACHE II: a severity of disease classification system

Efficacy and safety of recombinant human activated protein C for severe sepsis

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Advanced statistics: missing data in clinical research--part 1: an introduction and conceptual framework.

Bacterial infections in liver cirrhosis.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

P304

2305-2315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.25931

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264264134

http://www.w3.org/2001/XMLSchema#string

P698

22753144

http://www.w3.org/2001/XMLSchema#string

P921

P932

3556696

http://www.w3.org/2001/XMLSchema#string